Abstract
The use of biologic disease modifying anti rheumatic drugs (bDMARDs) has revolutionized the treatment of rheumatoid arthritis (RA). Innovation in this filed is continuous and several innovative bDMARDs that are...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
